PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

ACS study finds early-onset colorectal cancer cases surge globally

ACS study finds early-onset colorectal cancer cases surge globally
2024-12-12
(Press-News.org) ATLANTA, December 11, 2024 — A new study led by American Cancer Society (ACS) researchers shows that early-onset colorectal cancer (CRC) incidence rates are rising in 27 of 50 countries/territories worldwide, 20 of which have either exclusive or faster increases for early-onset disease. In 14 countries, including the United States, rates are increasing in young adults while stabilizing in those 50 years and older. The research is published today in the journal The Lancet Oncology.

“The increase in early-onset colorectal cancer is a global phenomenon,” said Dr. Hyuna Sung, senior principal scientist, cancer surveillance research at the American Cancer Society and lead author of the study. “Previous studies have shown this rise in predominately high-income Western countries, but now, it is documented in various economies and regions worldwide.”

The primary study objective was to examine contemporary CRC incidence trends in young versus older adults using data through 2017 from 50 countries/territories. Data were compiled using the Cancer Incidence in Five Continents Plus and trends were examined for age-standardized incidence rates of CRC ranging from 1943-2017. Temporal trends were visualized and quantified by age at diagnosis (25-49 years and 50-74 years). Average annual percentage changes (AAPC) were estimated for the last 10 years of data.

During the past decade, incidence rates of early-onset CRC (25-49 years) were stable in 23 countries, but increased in 27 countries, with the greatest annual increases in New Zealand (4.0%), Chile (4.0%) and Puerto Rico (3.8%). Fourteen of the 27 countries/territories showed either stable (Puerto Rico, Argentina, Norway, France, Ireland) or decreasing rates (Israel, Canada, the USA, England, Germany, Scotland, Slovenia, Australia, and New Zealand) in older adults. The rise in early-onset CRC was faster among men than women in Chile, Puerto Rico, Argentina, Ecuador, Thailand, Sweden, Israel, and Croatia, while young women experienced faster increases in England, Norway, Australia, Türkiye, Costa Rica, and Scotland. For the remaining 13 countries with increasing trends in both age groups, the annual percentage increase in young compared to older adults was larger in Chile, Japan, Sweden, the Netherlands, Croatia, and Finland, smaller in Thailand, Martinique, Denmark, Costa Rica, and similar in Türkiye, Ecuador, and Belarus. For the last five years, the incidence rate of early-onset CRC was highest in Australia, Puerto Rico, New Zealand, the U.S., and the Republic of Korea (14 to 17 per 100,000) and lowest in Uganda and India (4 per 100,000).

“The global scope of this concerning trend highlights the need for innovative tools to prevent and control cancers linked to dietary habits, physical inactivity, and excess body weight. Ongoing efforts are essential to identify the additional factors behind these trends and to develop effective prevention strategies tailored to younger generations and local resources worldwide,” added Sung. “Raising awareness of the trend and the distinct symptoms of early-onset colorectal cancer (e.g., rectal bleeding, abdominal pain, altered bowel habits, and unexplained weight loss) among young people and primary care providers can help reduce delays in diagnosis and decrease mortality.”

“This flagship study reveals that increasing rates of early onset bowel cancer, affecting adults aged 25-49, is a global issue. Concerningly, this research has revealed for the first time ever that rates are rising more sharply in England than in many other countries around the world,” said Michelle Mitchell, chief executive of Cancer Research UK. "A cancer diagnosis at any age has a huge impact on patients and their families - so while it's important to note that rates in younger adults are still very low compared to people over 50,  we need to understand what’s causing this trend in younger people. More research is needed - like team PROSPECT, a global Cancer Grand Challenges team who has been awarded £20m to uncover the causes of bowel cancer in younger adults, and strategies to prevent it."

Other ACS researchers contributing to the study include Rebecca Siegel, Chenxi Jiang, and senior author Dr. Ahmedin Jemal. Yin Cao, an associate professor of surgery and of medicine at Washington University School of Medicine in St. Louis and a research member of Siteman Cancer Center, based at Barnes-Jewish Hospital and Washington University Medicine, is a contributing author.

For more information on colorectal cancer, read here.

# # #

About the American Cancer Society
The American Cancer Society is a leading cancer-fighting organization with a vision to end cancer as we know it, for everyone. For more than 110 years, we have been improving the lives of people with cancer and their families as the only organization combating cancer through advocacy, research, and patient support. We are committed to ensuring everyone has an opportunity to prevent, detect, treat, and survive cancer. To learn more, visit cancer.org or call our 24/7 helpline at 1-800-227-2345. Connect with us on Facebook, X, and Instagram.

END


[Attachments] See images for this press release:
ACS study finds early-onset colorectal cancer cases surge globally

ELSE PRESS RELEASES FROM THIS DATE:

Fluctuating blood pressure tied to problems with thinking skills

2024-12-11
EMBARGOED FOR RELEASE UNTIL 4 P.M. ET, WEDNESDAY, DECEMBER 11, 2024 MINNEAPOLIS – Older adults whose blood pressure fluctuates over time may be more likely to have problems with thinking and memory skills, according to a study published in the December 11, 2024, online issue of Neurology®, the medical journal of the American Academy of Neurology. The association was found in Black participants but not in white participants in the study.   The study does not prove that fluctuations in blood pressure cause problems with thinking skills; it only shows an association. “These results suggest ...

Scientists find promising new target for antidepressants—in the gut

2024-12-11
Researchers have discovered new connections between the gut and brain that hold promise for more targeted treatments for depression and anxiety, and could help prevent digestive issues in children by limiting the transmission of antidepressants during pregnancy.  The study, published in the journal Gastroenterology, shows that increasing serotonin in the gut epithelium—the thin layer of cells lining the small and large intestines—improves symptoms of anxiety and depression in animal studies. The researchers also found ...

Antidepressants may act in gut to reduce depression and anxiety

2024-12-11
NEW YORK, NY (Dec. 11, 2024)--Most of us have experienced the effects of moods and emotions on our gastrointestinal tract, from “butterflies” in the stomach caused by nervousness to a loss of appetite when we’re feeling blue. A new study in animals suggests that targeting antidepressant medications to cells in the gut could not only be an effective treatment of mood disorders like depression and anxiety but may also cause fewer cognitive, gastrointestinal, and behavioral side effects for patients and their children than current treatments. “Antidepressants like Prozac and Zoloft that raise serotonin levels are important first-line ...

New PROSPECT-lung trial launches to advance treatment options for operable non-small cell lung cancer

2024-12-11
The highly anticipated PROSPECT-Lung trial has officially opened, marking a significant step forward in the quest to improve treatment strategies for patients with resectable non-small cell lung cancer. The trial, which is the first to open through the newly formed National Cancer Institute (NCI) Clinical Trials Innovation Unit (CTIU), aims to evaluate the role of immunotherapy before and after surgery in patients with non-small cell lung cancer. The PROSPECT-Lung trial is a large, multicenter trial developed and led by the Alliance for Clinical Trials in Oncology and the SWOG Cancer Research Network and conducted within the NIH-funded NCI National Clinical Trials Network (NCTN), ...

The Welch Foundation honors Rice’s Wang for pioneering contributions to sustainable energy solutions

The Welch Foundation honors Rice’s Wang for pioneering contributions to sustainable energy solutions
2024-12-11
The Welch Foundation, one of the nation’s leading private funders of basic chemistry research, has awarded the 2025 Norman Hackerman Award in Chemical Research to Haotian Wang, an associate professor in the Department of Chemical and Biomolecular Engineering at Rice University. Wang is recognized for his groundbreaking contributions to carbon dioxide electrochemistry, which pave the way for sustainable energy solutions. Wang’s innovative research focuses on harnessing the catalyst-electrolyte ...

Hospital payment caps could save millions of dollars for state employee health plans

2024-12-11
PROVIDENCE, R.I. [Brown University] — State employee health plans could have saved $7.1 billion nationwide by capping hospital payments at 200% of Medicare rates in 2022, a study led by researchers at the Brown University School of Public Health found. “States are under growing budgetary pressure due to rising health care spending, primarily through increases in hospital and drug prices,” said study author Roslyn Murray, an assistant professor of health services, policy and practice ...

Intraarterial radionuclide therapy safe and effective for advanced meningioma patients

Intraarterial radionuclide therapy safe and effective for advanced meningioma patients
2024-12-11
Reston, VA (December 10, 2024)—Radionuclide therapy delivered directly to an artery is safe and feasible for patients with advanced meningioma, according to new research published in the December issue of The Journal of Nuclear Medicine. In the first long-term study of intraarterial peptide receptor radionuclide therapy (PRRT) in advanced meningioma, patients saw improved radiologic and clinical disease control compared with intravenous PRRT, with no additional toxicity. Meningiomas are the most common primary neoplasms of the central nervous system and account for more than one-third of all cases. Meningiomas are mostly ...

University of Tennessee and Sheffield sign MOU to facilitate collaborations

University of Tennessee and Sheffield sign MOU to facilitate collaborations
2024-12-11
The University of Tennessee and the University of Sheffield recently signed a memorandum of understanding to facilitate educational and research collaborations, share best practices, and promote student and staff exchanges between the institutions.   Tickle College of Engineering Dean Matthew Mench, the Wayne T. Davis Dean’s Chair, traveled to England in late November to tour the Sheffield facilities, meet with faculty, and sign the MOU with Malcolm Butler, the vice president and director of global engagement of the University of Sheffield.  There ...

Nemours Children’s Health Initiative to start HPV vaccination at age 9 improved completion rates

2024-12-11
WILMINGTON, Del. (December 11, 2024) — A quality improvement program designed to increase earlier uptake of the human papillomavirus (HPV) vaccine raised vaccination rates significantly, according to a study by Nemours Children’s Health researchers. In a new study published in Academic Pediatrics, Caitlin J. Miller, medical student at Sidney Kimmel Medical College of Thomas Jefferson University and Jonathan Miller, MD, Associate Chief of Primary Care, Nemours Children’s ...

Nova SBE and New York University Tandon School of Engineering launch transatlantic dual degree program

2024-12-11
Nova School of Business and Economics (Nova SBE) has partnered with NYU Tandon School of Engineering  to  create a transatlantic program focusing on two strategic and complementary fields: Management (Nova SBE) and Management of Technology (NYU Tandon). This new program allows students to earn distinct master’s degrees from two of the world’s most prestigious academic institutions, located in key cultural and economic centers: Lisbon and New York.  Under this partnership agreement, students enrolled in either the International Master’s in Management or the Master’s in Management (both from Nova SBE) ...

LAST 30 PRESS RELEASES:

From leadership to influencers: New ASU study shows why we choose to follow others

‘Celtic curse’ genetic disease hotspots revealed in UK and Ireland

Study reveals two huge hot blobs of rock influence Earth’s magnetic field

RCT demonstrates effectiveness of mylovia, a digital therapy for female sexual dysfunction

Wistar scientists demonstrate first-ever single-shot HIV vaccine neutralization success

Medical AI models need more context to prepare for the clinic

Psilocybin shows context-dependent effects on social behavior and inflammation in female mice modeling anorexia

Mental health crisis: Global surveys expose who falls through the cracks and how to catch them

New boron compounds pave the way for easier drug development

Are cats ‘vegan’ meat eaters? Study finds why isotopic fingerprint of cat fur could trick us into thinking that way

Unexpected partial recovery of natural vision observed after intracortical microstimulation in a blind patient

From sea to soil: Molecular changes suggest how algae evolved into plants

Landmark study to explore whether noise levels in nurseries affect babies’ language development

Everyday diabetes medicine could treat common cause of blindness

Ultra-thin metasurface chip turns invisible infrared light into steerable visible beams

Cluster radioactivity in extreme laser fields: A theoretical exploration

Study finds banning energy disconnections shouldn’t destabilise markets

Researchers identify novel RNA linked to cancer patient survival

Poverty intervention program in Bangladesh may reinforce gender gaps, study shows

Novel approach to a key biofuel production step captures an elusive energy source

‘Ghost’ providers hinder access to health care for Medicaid patients

Study suggests far fewer cervical cancer screenings are needed for HPV‑vaccinated women

NUS CDE researchers develop new AI approach that keeps long-term climate simulations stable and accurate

UM School of Medicine launches clinical trial of investigative nasal spray medicine to prevent illnesses from respiratory viruses

Research spotlight: Use of glucose-lowering SGLT2i drugs may help patients with gout and diabetes take fewer medications

Genetic system makes worker cells more resilient producers of nanostructures for advanced sensing, therapeutics

New AI model can assist with early warning for coral bleaching risk

Highly selective asymmetric 1,6-addition of aliphatic Grignard reagents to α,β,γ,δ-unsaturated carbonyl compounds

Black and Latino teens show strong digital literacy

Aging brains pile up damaged proteins

[Press-News.org] ACS study finds early-onset colorectal cancer cases surge globally